Featured Posts from Our CEO

Featured Posts from Our CEO2017-03-24T12:47:26+00:00

New Kaiser Permanente Study Reveals an Increase in Marijuana Use During Pregnancy

Kelly Young-Wolff, PhD, KP Division of Research, and Nancy Goler, MD, discuss their study addressing the increase in maternal prenatal marijuana use, and how the results fill a critical data gap in understanding marijuana use among pregnant women.

Kaiser Permanente Study Shows New Program Cuts Stroke Treatment Time in Half

Drs. Vivek Rao, MD, Sunil Bhopale, MD, and Alexander Flint, MD describe how diagnosis and treatment times are cut in half by Kaiser’s “Stroke EXPRESS” carts, leading to greater outcomes for stroke victims.

Urban American-Indian and Alaskan Natives May Have Lower Survival Following Invasive Prostate and Breast Cancer

Laurel A. Habel, PhD discusses research from TPMG's Division of Research that finds urban American-Indian and Alaskan Native communities are more likely to have lower survival rates following invasive prostate and breast cancer.

Indivior’s Experimental Drug to Fight Opioid Addiction is Approved by the US FDA

Laurel Habel, Ph.D, from TPMG's Division of Research, describes Indivior as a promising alternative to the current addiction medication and believes it will be helpful to patients.